Yucesan Emrah, Goncu Beyza, Basoglu Harun, Ozten Kandas Nur, Ersoy Yeliz Emine, Akbas Fahri, Aysan Erhan
Institute of Life Sciences and Biotechnology, Bezmialem Vakif University, Istanbul, Turkey.
Experimental Research Center, Bezmialem Vakif University, Istanbul, Turkey.
Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13086. Epub 2017 Oct 16.
Permanent hypoparathyroidism is a serious problem and requires medications indefinitely. Parathyroid allotransplantation (PA) with short-term immunosuppression is definitive choice but long-term results are not clear.
We performed PA from two donors to two recipients. Both recipients were 39-year-old females. Donors were a 32-year-old female and a 36-year-old male, who both have chronic kidney disease. Routine tests, viral markers, and cross-matches were analyzed individually. The parathyroid glands were resected from the living donors, fragmented quickly in the operation room and injected into the left deltoid muscles of the two recipients.
Methylprednisolone was administered on post-PA day one and two. Recipients were discharged from the hospital without complications. Calcium and PTH levels were observed throughout 1 year. We did not observe any complications during the follow-up period. Medications ceased in post-transplantation week 1 for Case 1 and after 1 month for Case 2.
Fresh tissue PA with short-term immunosuppression appears to be a promising technique that is easy to perform, is cost-effective, has low risk of side effects and minimal complications with compatibility for HLA conditions. A longer follow-up period and more case studies are needed to determine the risks and benefits of this procedure for future cases.
永久性甲状旁腺功能减退是一个严重问题,需要长期用药。短期免疫抑制的甲状旁腺同种异体移植(PA)是一种确定性选择,但长期效果尚不清楚。
我们对两名受者进行了来自两名供者的PA。两名受者均为39岁女性。供者分别是一名32岁女性和一名36岁男性,二者均患有慢性肾病。对常规检查、病毒标志物和交叉配型进行了单独分析。从活体供者身上切除甲状旁腺,在手术室迅速切碎并注入两名受者的左三角肌。
在PA术后第1天和第2天给予甲泼尼龙。受者无并发症出院。在1年时间里观察血钙和甲状旁腺激素水平。随访期间未观察到任何并发症。病例1在移植后第1周停药,病例2在1个月后停药。
短期免疫抑制的新鲜组织PA似乎是一种很有前景的技术,操作简便、成本效益高、副作用风险低、并发症极少,且与HLA条件兼容。需要更长的随访期和更多的病例研究来确定该手术对未来病例的风险和益处。